Global Clopidogrel Market Comprehensive Insight by Growth Rate, Industry Status, Forecast till 2027
The global clopidogrel market is anticipated to grow at a significant CAGR during the forecast period (2021-2027). The major factors that are expected to accelerate the growth of the market during the forecast period include the increased demand for clopidogrel among patients who are suffering from CVD and related problems. Moreover, the changing lifestyle and increase in the number of patients related to cardiovascular diseases among the emerging economies in the Asia Pacific region are further expected to drive the market growth during the forecast period. Moreover, the patent expiry of clopidogrel drugs is anticipated to open possibilities for various pharmaceutical companies to venture into the production of clopidogrel drugs.
To Request a Sample of our Report on Global Clopidogrel
Market: https://www.omrglobal.com/request-sample/clopidogrel-market
Clopidogrel is an antiplatelet agent of thienopyridine,
which is primarily used to prevent blood clots and support against CVD problems
associated with blood clotting. The medications used for inhibiting blood clots
after a recent heart stroke also involves the use of clopidogrel, which is a
white-coloured powder that is insoluble in water at neutral pH, however, freely
soluble at pH1. Sold under the brand name Plavix, and marketed by Sanofi and
Bristol-Myers Squibb, the demand for clopidogrel is escalating owing to the
increasing number of heart attack cases across the globe. Furthermore,
several other organizations such as Roxane Laboratories, Aurobindo Pharma Ltd.,
Sun Pharmaceutical Industries Ltd., Torrent Pharmaceuticals Ltd., and Apotex
Inc., have gained approval for marketing clopidogrel 75mg. Clopidogrel is also
used with aspirin to treat worsening chest pain and keep blood vessels open and
prevent blood clots after certain heart-related operations. According to
the World Heart Federation, nearly 15 million people suffer from heart attack or
related problems globally. Out of these, roughly six million of these patients
die while another five million are disabled permanently. This vast patient base
is the primary factor that will sustain the demand for clopidogrel during the
forecast period.
Market Coverage
·
The market number available for – 2020-2027
·
Base year- 2020
·
Forecast period- 2021-2027
·
Segment Covered
·
Regions Covered- Globally
·
Competitive Landscape: Sanofi S.A., Bristol
Myers Squibb Co., and Sun Pharmaceutical Industries Ltd., among others.
(Get 15% Discount on Buying this Report)
A
full Report of Global Clopidogrel Market is Available at: https://www.omrglobal.com/industry-reports/clopidogrel-market
Global Clopidogrel Market Report by Segment
By Type
• 25 mg
• 75 mg
• 300 mg
By Application
• Hospitals
• Private Clinics
• Retail Pharmacies
• Online Pharmacies
• Others
Global Clopidogrel Market by Region
North America
·
United States
·
Canada
Europe
·
UK
·
Germany
·
Spain
·
France
·
Italy
·
Rest of Europe
Asia-Pacific
·
India
·
China
·
Japan
·
South Korea
·
Rest of APAC
Rest of the World
·
Latin America
·
Middle East & Africa
Reasons to buy from us –
1. We cover more than
15 major industries, further segmented into more than 90 sectors.
2. More than 120
countries are for analysis.
3. Over 100+ paid
data sources mined for investigation.
4. Our expert
research analysts answer all your questions before and after purchasing your
report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company
known for its crisp and concise reports. The company is equipped with an
experienced team of analysts and consultants. OMR offers quality syndicated
research reports, customized research reports, consulting and other
research-based services.
Media
Contact:
Company
Name: Orion Market Research
Contact
Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact
no: +91 7803040404
Comments
Post a Comment